Methylxanthines are primarily used in neonatology to manage and treat apnea of prematurity, a common condition where premature infants experience pauses in breathing due to an underdeveloped respiratory system. The most commonly used methylxanthine in this context is caffeine, due to its favorable safety profile and efficacy.
